A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
Christina D. Drenberg(The Ohio State University), Sharyn D. Baker(The Ohio State University)
Cited by 41
Related Papers
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD–Positive AML
|Molecular Cancer Therapeutics|2021|45
Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia
|Journal of Clinical Investigation|2017|39